EHAB
Enhabit Inc.
NYSE: EHAB · HEALTHCARE · MEDICAL CARE FACILITIES
$13.78
-0.07% today
Updated 2026-05-11
Market cap
$706.40M
P/E ratio
—
P/S ratio
0.67x
EPS (TTM)
$-0.07
Dividend yield
—
52W range
$6 – $14
Volume
1.1M
WallStSmart proprietary scores
48
out of 100
Grade: C
Sell
Investment rating
5.3
Growth
C+6.0
Quality
B4.0
Profitability
C6.7
Valuation
B5/9
Piotroski F-Score
Moderate
1.7
Altman Z-Score
Distress
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$13.80
+0.15%
12-Month target
—
—
Intrinsic (DCF)
$50.06
Margin of safety
+77.55%
0 Strong Buy0 Buy6 Hold0 Sell0 Strong Sell
Price chart
Stock snapshot
Strengths
+ Free cash flow $32.70M — positive
+ 77.55% below intrinsic value
Risks
- Altman Z 1.71 — distress zone
- Thin margins at -0.43%
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $1.07B | $1.05B | $1.03B | $1.06B | $1.06B |
| Net income | $-40.40M | $-80.50M | $-156.20M | $-4.60M | $19.20M |
| EPS | — | — | — | — | $-0.07 |
| Free cash flow | $73.00M | $44.90M | $47.40M | $65.80M | $32.70M |
| Profit margin | -3.77% | -7.69% | -15.09% | -0.43% | -0.43% |
Recent insider activity
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| 2026-04-10 | SCHOCHET, BARRY P. | Buy | 1,698 | $13.99 |
| 2026-04-10 | RUSH, GREGORY S | Buy | 1,787 | $13.99 |
| 2026-04-10 | RODGERS, STEPHAN | Buy | 1,340 | $13.99 |
Peer comparison
Smart narrative
Enhabit Inc. trades at $13.78. Our Smart Value Score of 48/100 indicates the stock is fair. The company scores 5/9 on the Piotroski F-Score. With an Altman Z-Score of 1.71, it sits in the distress. TTM revenue stands at $1.06B. with profit margins at -0.43%. Our DCF model estimates intrinsic value at $50.06.
Frequently asked questions
What is Enhabit Inc.'s stock price?
Enhabit Inc. (EHAB) trades at $13.78.
Is Enhabit Inc. overvalued?
Smart Value Score 48/100 (Grade C, Sell). DCF value $50.06.
What is the price target of Enhabit Inc. (EHAB)?
The analyst target price is $13.80, representing +0.1% upside from the current price of $13.78.
What is the intrinsic value of Enhabit Inc. (EHAB)?
Based on our DCF model, intrinsic value is $50.06, a +77.5% margin of safety versus $13.78.
What is Enhabit Inc.'s revenue?
TTM revenue is $1.06B.
Piotroski F-Score?
5/9 — moderate financial health.
Altman Z-Score?
1.71 — distress.
Company info
SectorHEALTHCARE
IndustryMEDICAL CARE FACILITIES
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio0.67x
ROE-0.47%
Beta0.96
50D MA$13.75
200D MA$10.12
Shares out0.05B
Float0.04B
Short ratio—
Avg volume1.1M
Performance
1 week+0.36%
1 month-1.36%
3 months+23.24%
YTD+49.57%
1 year—
3 years—
5 years—